Penumbra, Inc. (PEN) Reports Q2 EPS of $0.01, Raises FY Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Penumbra, Inc. Reports Second Quarter 2016 Financial Results
August 9, 2016 4:05 PM EDTALAMEDA, Calif., Aug. 9, 2016 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today reported financial results for the second quarter ended June 30, 2016.
Revenue of $65.1 million in the second quarter of 2016, an increase of 53.9%, or 53.2% in constant currency1, over the second quarter of 2015.Second Quarter 2016 Financial ResultsTotal revenue grew to $65.1 million for the second quarter of... More
